Intellicheck (NASDAQ:IDN) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 20 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $4.80 million which beat the analyst consensus estimate of $3.18 million by 50.94 percent. This is a 160.59 percent increase over sales of $1.84 million the same period last year.
JP Morgan Initiates Coverage On Omeros with Neutral Rating, Announces Price Target of $15
JP Morgan analyst Eric Joseph initiates coverage on Omeros (NASDAQ:OMER) with a Neutral rating and announces Price Target of $15.
